Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Drug Therapy × NET × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Gastrointestinal 38 Breast 27 Thoracic 16 Head & Neck 7 Gynecologic 6 Sarcoma 5 Other hematologic neoplasm 5 Lymphoid 5 Genitourinary 4 Tumor-Agnostic 3 Dermatologic 3 Plasma cell 2 CNS 2 NET 1 Myeloid 1 Endocrine 1 Classical hematology 1

Conditions

Neuroendocrine Tumors 1 Carcinoma, Neuroendocrine 1

Interventions

lutetium Lu 177 dotatate 6 Magnetic Resonance Spectroscopy 3 Data Collection 3 telotristat ethyl 2 Somatostatin 2 Everolimus 2 Biopsy 2 surufatinib 1 lanreotide 1 copper dotatate CU-64 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Sorafenib 1 Salvage Therapy 1 Radionuclide Imaging 1 Radiomics 1 Radiofrequency Ablation 1 Positron-Emission Tomography 1 Plastic Surgery Procedures 1 Phlebotomy 1 Octreotide 1 Lutetium-177 1 Lutetium 1 Liver Transplantation 1 Laparoscopy 1 Electronic Health Records 1 Drug Therapy 1 Diet, Mediterranean 1 Cytidine Triphosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04464122 2025-04-03

REBORN

University of Roma La Sapienza

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡